|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Research and development expense | |||||
| Amortization of intangibles | |||||
| Impairment of intangibles | |||||
| Operating income | |||||
| Interest expense | |||||
| Other expense | |||||
| Income before income taxes | |||||
| Provision for income taxes (Note 6) | |||||
| Net income | |||||
| Earnings per share (Note 7) | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Number of shares used to compute earnings per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
